Literature DB >> 30858343

Cooperative Interactions between Trichomonas vaginalis and Associated Bacteria Enhance Paracellular Permeability of the Cervicovaginal Epithelium by Dysregulating Tight Junctions.

Annabel S Hinderfeld1, Niha Phukan1, Ann-Katrein Bär1, Anthony M Roberton1, Augusto Simoes-Barbosa2.   

Abstract

The human protozoan Trichomonas vaginalis is the causative agent of trichomoniasis, a prevalent sexually transmitted infection, which is accompanied by a species-diversified vaginal microbiota named community state type IV (CST-IV). Coincidently, CST-IV includes species associated with bacterial vaginosis (e.g. Gardnerella vaginalis, Atopobium vaginae, and Prevotella bivia). Both diseases are linked to the transmission of human immunodeficiency virus (HIV) and preterm birth, which complications are likely to result from the disruption of the cervicovaginal epithelial barrier. Here, we show that paracellular permeability of fluorescein isothiocyanate (FITC)-dextran through a monolayer of human ectocervical cells (hECs) is increased as a consequence of the activity of T. vaginalis and the aforementioned species of CST-IV bacteria cooperatively. T. vaginalis enhances paracellular permeability of hECs two times more than the individual bacterial species, by up to ∼10% versus ∼5%, respectively. However, any two or all three bacterial species are capable of synergizing this effect. T. vaginalis and the bacteria together increase the paracellular permeability of hECs by ∼50%, which is 5 to 10 times more than the results seen with the protozoan or bacteria alone. This effect is accompanied by enhancement of phosphatase activity, while phosphatase inhibition results in preservation of the integrity of the ectocervical cell monolayer. In addition, these microorganisms induce changes in the expression of tight junction proteins, particularly occludin, and of proinflammatory cytokines interleukin-6 (IL-6) and tumor necrosis factor alpha (TNF-α). Together, our findings establish that cooperative interactions between CST-IV bacteria and T. vaginalis enhance the paracellular permeability of the cervicovaginal epithelium by disturbing the integrity of the tight junction complex. Our study results highlight the importance of understanding the contribution of the vaginal microbiota to trichomoniasis.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  Trichomonas vaginaliszzm321990; bacterial vaginosis; microbial cooperation; microbial synergism; paracellular permeability; phosphatase; tight junctions; vaginal epithelium; vaginal microbiota

Mesh:

Year:  2019        PMID: 30858343      PMCID: PMC6479042          DOI: 10.1128/IAI.00141-19

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  56 in total

1.  Perspectives on tight junction research.

Authors:  Jörg-Dieter Schulzke; Dorothee Günzel; Lena J John; Michael Fromm
Journal:  Ann N Y Acad Sci       Date:  2012-06       Impact factor: 5.691

Review 2.  Inflammatory disease caused by intestinal pathobionts.

Authors:  Ellen L Zechner
Journal:  Curr Opin Microbiol       Date:  2017-02-10       Impact factor: 7.934

Review 3.  The vaginal microbiome, vaginal anti-microbial defence mechanisms and the clinical challenge of reducing infection-related preterm birth.

Authors:  S S Witkin
Journal:  BJOG       Date:  2014-10-15       Impact factor: 6.531

4.  Trichomonas vaginalis lipophosphoglycan mutants have reduced adherence and cytotoxicity to human ectocervical cells.

Authors:  Felix D Bastida-Corcuera; Cheryl Y Okumura; Angie Colocoussi; Patricia J Johnson
Journal:  Eukaryot Cell       Date:  2005-11

5.  Vaginal lactobacilli, microbial flora, and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition.

Authors:  H L Martin; B A Richardson; P M Nyange; L Lavreys; S L Hillier; B Chohan; K Mandaliya; J O Ndinya-Achola; J Bwayo; J Kreiss
Journal:  J Infect Dis       Date:  1999-12       Impact factor: 5.226

6.  A Cell Surface Aggregation-Promoting Factor from Lactobacillus gasseri Contributes to Inhibition of Trichomonas vaginalis Adhesion to Human Vaginal Ectocervical Cells.

Authors:  Niha Phukan; Anna E S Brooks; Augusto Simoes-Barbosa
Journal:  Infect Immun       Date:  2018-07-23       Impact factor: 3.441

7.  Characterization of an ecto-phosphatase activity in the human parasite Trichomonas vaginalis.

Authors:  J B de Jesus; T M Podlyska; A Hampshire; C S Lopes; M A Vannier-Santos; J R Meyer-Fernandes
Journal:  Parasitol Res       Date:  2002-07-13       Impact factor: 2.289

8.  Proteome analysis of the surface of Trichomonas vaginalis reveals novel proteins and strain-dependent differential expression.

Authors:  Natalia de Miguel; Gil Lustig; Olivia Twu; Arnab Chattopadhyay; James A Wohlschlegel; Patricia J Johnson
Journal:  Mol Cell Proteomics       Date:  2010-05-13       Impact factor: 5.911

9.  Trichomonas vaginalis associated with low birth weight and preterm delivery. The Vaginal Infections and Prematurity Study Group.

Authors:  M F Cotch; J G Pastorek; R P Nugent; S L Hillier; R S Gibbs; D H Martin; D A Eschenbach; R Edelman; J C Carey; J A Regan; M A Krohn; M A Klebanoff; A V Rao; G G Rhoads
Journal:  Sex Transm Dis       Date:  1997-07       Impact factor: 2.830

10.  Proteinase inhibitors TPCK and TLCK prevent Entamoeba histolytica induced disturbance of tight junctions and microvilli in enteric cell layers in vitro.

Authors:  Tineke Lauwaet; Maria José Oliveira; Bert Callewaert; Georges De Bruyne; Marc Mareel; Ancy Leroy
Journal:  Int J Parasitol       Date:  2004-06       Impact factor: 3.981

View more
  11 in total

1.  Mucosal microbial parasites/symbionts in health and disease: an integrative overview.

Authors:  Robert P Hirt
Journal:  Parasitology       Date:  2019-08       Impact factor: 3.234

Review 2.  Polymicrobial Interactions Operative during Pathogen Transmission.

Authors:  Hannah M Rowe; Jason W Rosch
Journal:  mBio       Date:  2021-05-18       Impact factor: 7.867

Review 3.  Impact of Symbiosis Between Trichomonas vaginalis and Mycoplasma hominis on Vaginal Dysbiosis: A Mini Review.

Authors:  Valentina Margarita; Pier Luigi Fiori; Paola Rappelli
Journal:  Front Cell Infect Microbiol       Date:  2020-05-08       Impact factor: 5.293

4.  Development of a convenient detection method for Trichomonas vaginalis based on loop-mediated isothermal amplification targeting adhesion protein 65.

Authors:  Yuhua Li; Shuai Wang; Haoran Li; Xiaoxiao Song; Hao Zhang; Yujuan Duan; Chengyang Luo; Bingli Wang; Sifan Ji; Qing Xie; Zhenchao Zhang
Journal:  BMC Infect Dis       Date:  2020-05-01       Impact factor: 3.090

Review 5.  Anti-trichomonad activities of different compounds from foods, marine products, and medicinal plants: a review.

Authors:  Mendel Friedman; Christina C Tam; Luisa W Cheng; Kirkwood M Land
Journal:  BMC Complement Med Ther       Date:  2020-09-09

6.  Dysbiosis of fecal microbiota in cats with naturally occurring and experimentally induced Tritrichomonas foetus infection.

Authors:  Metzere Bierlein; Barry A Hedgespeth; M Andrea Azcarate-Peril; Stephen H Stauffer; Jody L Gookin
Journal:  PLoS One       Date:  2021-02-19       Impact factor: 3.240

Review 7.  Recent advances in the molecular biology of the protist parasite Trichomonas vaginalis.

Authors:  David Leitsch
Journal:  Fac Rev       Date:  2021-03-04

8.  Gardnerella vaginalis alters cervicovaginal epithelial cell function through microbe-specific immune responses.

Authors:  Lauren Anton; Briana Ferguson; Elliot S Friedman; Kristin D Gerson; Amy G Brown; Michal A Elovitz
Journal:  Microbiome       Date:  2022-08-04       Impact factor: 16.837

9.  Analysis of characteristics of vulvo-vaginal infections in 14- to 18-year-old girls in late puberty.

Authors:  Ling Xu; Zhengqiang Hu; Fan Yu; Yuanting Tang
Journal:  J Int Med Res       Date:  2020-08       Impact factor: 1.671

Review 10.  Bacterial-Viral Interactions in Human Orodigestive and Female Genital Tract Cancers: A Summary of Epidemiologic and Laboratory Evidence.

Authors:  Ikuko Kato; Jilei Zhang; Jun Sun
Journal:  Cancers (Basel)       Date:  2022-01-15       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.